Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2023-09-14 00:00:00 ET · period of report 2023-09-14 · accession 0001127602-23-024201 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-14 | 2023-09-14 | LXRX | WADE JEFFREY L | Pres, CFO | P - Purchase | $1.38 | +10.0K | 264.3K | +4% | +$13.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-14 | P | A | 10,000 | $1.38 | 264,341 | D | — | — |